Proteomics approach for prediction of immunogenic site from Footand- mouth disease virus

Gomase V.S1*, Phadnis A. C.2, Tripathi A.K.3
1Proteomics Unit, Department of Bioinformatics, Padmashree Dr. D. Y. Patil University, Plot No-50, Sector-15, CBD Belapur, Navi Mumbai, 400614, MS, India
2Proteomics Unit, Department of Bioinformatics, Padmashree Dr. D. Y. Patil University, Plot No-50, Sector-15, CBD Belapur, Navi Mumbai, 400614, MS, India
3Proteomics Unit, Department of Bioinformatics, Padmashree Dr. D. Y. Patil University, Plot No-50, Sector-15, CBD Belapur, Navi Mumbai, 400614, MS, India
* Corresponding Author : virusgene1@ yahoo.co.in

Received : -     Accepted : -     Published : 15-06-2009
Volume : 1     Issue : 1       Pages : 1 - 3
Int J Biotechnol Appl 1.1 (2009):1-3
DOI : http://dx.doi.org/10.9735/0975-2943.1.1.1-3

Keywords : Antigen, Epitope, PSSM, SVM, MHC, Peptide vaccine
Conflict of Interest : None declared

Cite - MLA : Gomase V.S, et al "Proteomics approach for prediction of immunogenic site from Footand- mouth disease virus." International Journal of Biotechnology Applications 1.1 (2009):1-3. http://dx.doi.org/10.9735/0975-2943.1.1.1-3

Cite - APA : Gomase V.S, Phadnis A. C., Tripathi A.K. (2009). Proteomics approach for prediction of immunogenic site from Footand- mouth disease virus. International Journal of Biotechnology Applications, 1 (1), 1-3. http://dx.doi.org/10.9735/0975-2943.1.1.1-3

Cite - Chicago : Gomase V.S, Phadnis A. C., and Tripathi A.K. "Proteomics approach for prediction of immunogenic site from Footand- mouth disease virus." International Journal of Biotechnology Applications 1, no. 1 (2009):1-3. http://dx.doi.org/10.9735/0975-2943.1.1.1-3

Copyright : © 2009, Gomase V.S, et al, Published by Bioinfo Publications. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Abstract

Foot-and-mouth disease is caused by FMDV, an Aphthovirus of the viral family Picornaviridae. Peptide fragments of Foot-and-mouth disease virus protein can be used to select nonamers for use in rational vaccine design and to increase the understanding of roles of the immune system in infectious diseases. Analysis shows MHC class II binding peptides of protein from Footand-mouth disease virus are important determinant for protection of host form viral infection. In this assay we predicted the binding affinity of protein having 213 amino acids, which shows nonamers. These peptides are from a set of aligned peptides known to bind to a given MHC molecule as the predictor of MHC-peptide binding. MHCII molecules bind peptides in similar yet different modes and alignments of MHCII-ligands were obtained to be consistent with the binding mode of the peptides to their MHC class, this means the increase in affinity of MHC binding peptides may result in enhancement of immunogenicity of protein nonamers. Binding ability prediction of antigen peptides to major histocompatibility complex (MHC) class I & II molecules is important in vaccine development from Foot-and-mouth disease virus.

References

[1] Jinding C., Mingqiu Z., Hui, K.H., Leung F.C. (2006) Virus Genes. 32(2):139-43.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[1] López-Revilla R., Pineda M.A., Ortiz- Valdez J., Sánchez-Garza M., Riego L. (2009) Infect Agent Cancer 4, 3  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[2] Mohabatkar H. (2007) Asian Pac J Cancer Prev. 8(4), 602-6.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[3] Gomase V.S. and Kale K.V. (2007) National Symposium on Genomics, Proteomics and Bioinformatics, Osmanabad, India  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[4] Gomase V.S., Kale K.V., Jyotiraj A. and Vasanthi R. (2007) Medicinal Chemistry Research, 15(1/6), 160.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[5] Gomase V.S., Kale K.V., Shyamkumar K. and Shankar S. (2008) ICETET 2008, IEEE Computer Society in IEEE Xplore, Los Alamitos, California, 629-634.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[6] Reche P.A., Glutting J.P. and Reinherz E.L. (2002) Hum Immunol., 63(9), 701-709  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[7] Buus S., Lauemøller S.L., Worning P., Kesmir C., Frimurer T., Corbet S., Fomsgaard A., Hilden J., Holm A., Brunak S. (2003) Tissue Antigens, 62 (5), 378-384  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[8] Nielsen M., Lundegaard C., Worning P., Lauemøller S.L., Lamberth K., Buus S., Brunak S., Lund O. (2003) Protein Sci., 12 (5), 1007-1017  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[9] Bhasin M. and Raghava G.P. (2005) Nucleic Acids Res., 33, W202-207  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[10] Gomase V. S., Tandale J.P., Patil S. A. and Kale K.V. (2006) 14th International Conference on Advance Computing & Communication, ADCOM06, Published by IEEE Computer Society in IEEE Xplore USA, 614-615  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[11] Gomase V.S., Kale K.V., Chikhale N.J., Changbhale S.S. (2007) Curr. Drug Discov. Technol., 4(2), 117-1215  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus  

[12] Gomase V.S., Waghmare S.B., Jadhav B.V., Kale K.V. (2009) Gene Therapy and Molecular Biology, 13, 11-15.  
» CrossRef   » Google Scholar   » PubMed   » DOAJ   » CAS   » Scopus